| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| GTO ID | GTC3972 |
| Trial ID | NCT03213054 |
| Disease | Esophageal Cancer |
| Altered gene | E1A|E1B|TERT |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | Telomelysin|OBP-301 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Phase 1 Study to Evaluate the Safety of OBP-301, Telomelysin in Combination With Radiation Therapy in Patients With Esophageal Cancer Not Applicable for Standard Therapy |
| Year | 2017 |
| Country | Japan |
| Company sponsor | Oncolys BioPharma Inc |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||||||
|
|||||||||